Evidence map›Paper›PMID 40407599›Full record

ArticlePathophysiology : the official journal of the International Society for Pathophysiology2025

Therapeutic Efficacy of Mesenchymal Stem Cells in Modulating Oxidative Stress in Puromycin-Induced Nephropathy.

Yusuke Iizuka, Masanori Sasaki, Kojiro Terada, Takuro Sakai, Yoshinobu Nagaoka, Shinobu Fukumura, Jeffery D Kocsis, Takeshi Tsugawa, Osamu Honmou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathophysiology : the official journal of the International Society for Pathophysiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yusuke IizukaDepartment of Pediatrics, Sapporo Medical University School of Medicine, Sapporo 060-8556, Hokkaido, Japan.
Masanori SasakiDepartment of Neural Regenerative Medicine, Institute of Regenerative Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8556, Hokkaido, Japan.ORCID 0000-0001-7961-9698
Kojiro TeradaDepartment of Pediatrics, Sapporo Medical University School of Medicine, Sapporo 060-8556, Hokkaido, Japan.ORCID 0000-0002-2833-5078
Takuro SakaiDepartment of Pediatrics, Sapporo Medical University School of Medicine, Sapporo 060-8556, Hokkaido, Japan.
Yoshinobu NagaokaDepartment of Pediatrics, Sapporo Medical University School of Medicine, Sapporo 060-8556, Hokkaido, Japan.ORCID 0000-0002-7138-334X
Shinobu FukumuraDepartment of Pediatrics, Sapporo Medical University School of Medicine, Sapporo 060-8556, Hokkaido, Japan.ORCID 0000-0001-9829-4833
Jeffery D KocsisDepartment of Neurology, Yale University School of Medicine, New Haven, CT 06510, USA.ORCID 0000-0002-3780-7719
Takeshi TsugawaDepartment of Pediatrics, Sapporo Medical University School of Medicine, Sapporo 060-8556, Hokkaido, Japan.ORCID 0000-0001-7226-3000
Osamu HonmouDepartment of Neural Regenerative Medicine, Institute of Regenerative Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8556, Hokkaido, Japan.

Funding

Japan Society for the Promotion of Science 23K08095
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

intravenousmesenchymal stem cellminimal change diseasepuromycin aminonucleoside

Identifiers

PMID40407599
PMCPMC12101160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.